CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank50
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P50
Within normal range
vs 5Y Ago
-13.2x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
2025-12.90%+87.0%
2024-99.50%-100.1%
2023-49.71%+53.5%
2022-106.98%-146.3%
2021-43.43%-4550.2%
20200.98%+102.6%
2019-38.22%-203.2%
2018-12.61%-158.6%
201721.52%+2136.2%
2016-1.06%-